Edition:
United States

Synergy Pharmaceuticals Inc (SGYP.OQ)

SGYP.OQ on NASDAQ Stock Exchange Global Select Market

1.89USD
19 Jul 2018
Change (% chg)

-- (--)
Prev Close
$1.89
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
847,006
52-wk High
$4.36
52-wk Low
$1.42

Select another date:

Thu, May 10 2018

BRIEF-Synergy Pharmaceuticals Reports Q1 Loss Per Share $0.15

* SYNERGY PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND BUSINESS UPDATE

BRIEF-Synergy Pharmaceuticals Qtrly Loss Per Share ‍$0.16

* SYNERGY PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND BUSINESS UPDATE

BRIEF-Cipher Pharmaceuticals Acquires Exclusive Canadian Rights To FDA-Approved Trulance® From Synergy Pharma

* CIPHER PHARMACEUTICALS ACQUIRES EXCLUSIVE CANADIAN RIGHTS TO FDA-APPROVED TRULANCE® FROM SYNERGY PHARMACEUTICALS

BRIEF-Paulson & Co Dissolves Share Stake In Sprint, Cuts In Synergy Pharmaceuticals ‍​

* PAULSON & CO CUTS SHARE STAKE IN SYNERGY PHARMACEUTICALS TO 4 MILLION SHARES FROM 24.1 MILLION SHARES - SEC FILING

BRIEF-Synergy Pharma Meets Cash Balance Requirement

* SYNERGY PHARMACEUTICALS SAYS HAS MET CASH BALANCE REQUIREMENT TO ACCESS ADDITIONAL CAPITAL UNDER TERM LOAN AGREEMENT DATED SEPT 1, 2017 Source text for Eikon: Further company coverage:

BRIEF-Synergy Pharmaceuticals Announces FDA Approval Of TRULANCE

* SYNERGY PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF TRULANCE® (PLECANATIDE) FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) IN ADULTS

Select another date: